Oromyofunctional Training: an Innovative Rehabilitation Program for Pediatric Obstructive
Obstructive sleep apnea (OSA) is a prevalent medical condition with important implications for overall health and quality of life in both children. Therefore, it is important to treat OSA early and effectively. However, adenotonsillectomy, the standard therapeutic approach for children with OSA, is often inadequate. Re
| Condition(s) | Obstructive Sleep Apnea (OSA), Orofacial Myofunctional Disorders |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Obstructive sleep apnea (OSA) is a prevalent medical condition with important implications for overall health and quality of life in both children. Therefore, it is important to treat OSA early and effectively. However, adenotonsillectomy, the standard therapeutic approach for children with OSA, is often inadequate. Research shows that 20-40% of children still have residual OSA symptoms after surgery. Therefore, exploring other treatment options, specifically for those patients who currently have insufficient therapeutic options, is an interesting and relevant avenue for research. This study will evaluate the effectiveness of orofacial myofunctional therapy as a treatment option for children with obstructive sleep apnea (OSA). Orofacial myofunctional therapy consists of a set of oropharyng |
| Who can participate | Inclusion Criteria: * Children aged between 6-12 * Diagnosed with Obstructive Sleep Apnea on Polysomnography (AHI\<1) Exclusion Criteria: * History of Orofacial Myofunctional Therapy * Undergoing an orthodontic procedure during the study period * Undegoing an OSA treatment during the study period * Orofacial congenital deformities * Mental retardation (\>2 SD above P50) |
| Ages | 6 Years to 12 Years |
| Sex | All |
| Lead sponsor | University Ghent |
| Locations | Ghent, Belgium |
| Start date | 2024-08-08 |
| NCT ID | NCT07129967 |
| Official listing | https://clinicaltrials.gov/study/NCT07129967 |